Paeds SAQs · infectious-diseases
Vaccine-preventable disease outbreak response — formative SAQs
Formative SAQs on the systematic response to a vaccine-preventable disease outbreak in children: the stepwise management of a measles outbreak in an under-vaccinated school (isolation, IgM/PCR with genotyping, notification, contact triage, MMR within 72 hours and immunoglobulin within 6 days, exclusion, and catch-up vaccination above the herd-immunity threshold); and the management of an infant with apnoea and a household cough contact, including the public-health response to protect the household's newborn and pregnant contacts.
On this page
Study tools
Target exams
SAQ 1 (10 marks)
A 6-year-old child presents to the emergency department with four days of fever, cough, coryza and conjunctivitis. This morning a blotchy maculopapular rash appeared behind the ears and is spreading cephalocaudally. The child has never been vaccinated. The child attends a school where several other unvaccinated children have had a similar illness. In the waiting room there are infants and a woman who is 28 weeks pregnant. [3]
Question: Outline the immediate and stepwise outbreak response, including the management of the index case, the contact network and the prevention campaign. (10 marks) [1]
Model answer
Recognise, isolate and protect the waiting room (2 marks). This is classic measles — the 3 C's with Koplik-spots-equivalent prodrome and a cephalocaudal rash in an unvaccinated child with a school cluster. The single most important immediate act is airborne isolation (negative-pressure where available) and removal of the case from the waiting room, because measles lingers in the air for up to two hours. Identify the exposed waiting-room contacts, especially the pregnant woman and the infants, because they are the high-risk contacts who drive the prophylaxis triage. [3] [1]
Confirm and notify (2 marks). Confirm with measles IgM on a single serum plus RT-PCR and genotype on a throat/nasopharyngeal swab and urine; the genotype links the case to the school cluster and distinguishes imported from endemic transmission. Notify public health on clinical suspicion — do not wait for confirmation — because notification triggers the contact-tracing and prophylaxis cascade. [1] [2]
Build and triage the contact list (2 marks). Map the school, childcare, household and waiting-room exposures, and triage every contact by risk: who is pregnant (and at what gestation), who is under 6 to 12 months, and who is immunocompromised. These are the contacts who pay most for delay and who are prioritised for same-day prophylaxis. Document the infectious period — from four days before to four days after the rash — to define who was exposed. [2] [6]
Deliver post-exposure prophylaxis within the window (2 marks). Offer MMR within 72 hours of exposure to susceptible contacts; give normal human immunoglobulin within 6 days to the high-risk contacts who cannot receive the live vaccine — the pregnant woman, the immunocompromised child, and infants under 6 to 12 months. The window is narrow, so the contact-tracing effort must reach the high-risk contacts first. Exclude cases until four days after the rash and susceptible contacts through the incubation period. [1] [2]
Prevent — the catch-up campaign (2 marks). Run ring and catch-up vaccination across the affected school and community to lift two-dose coverage back above the herd-immunity threshold of about 95 per cent. The outbreak ends when the susceptible pool is closed, and the campaign is what closes it — as the Amish-community outbreak showed, rapid identification and aggressive vaccination interrupt transmission. Communicate honestly with the community, address vaccine hesitancy respectfully, and document so the programme learns. [7] [11]
References7ShowHide
- [1]WHO Measles vaccines: WHO position paper. Wkly Epidemiol Rec, 2009.PMID 19714924
- [2]McLean HQ; Fiebelkorn AP; Tempte JL; Wallace GS Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep, 2013.PMID 23760231
- [3]Perry RT; Halsey NA The clinical significance of measles: a review. J Infect Dis, 2004.PMID 15106083
- [4]WHO Pertussis vaccines: WHO position paper, August 2015--Recommendations. Vaccine, 2016.PMID 26562318
- [6]Phadke VK; Bednarczyk RA; Salmon DA; Omer SB Association Between Vaccine Refusal and Vaccine-Preventable Diseases in the United States: A Review of Measles and Pertussis. JAMA, 2016.PMID 26978210
- [7]Gastañaduy PA; Budd J; Fisher N; Redd SB; et al A Measles Outbreak in an Underimmunized Amish Community in Ohio. N Engl J Med, 2016.PMID 27705270
- [11]Funk S; Knapp JK; Lebo E; Reef SE; et al Combining serological and contact data to derive target immunity levels for achieving and maintaining measles elimination. BMC Med, 2019.PMID 31551070